Medicamen Biotech Ltd (MEDICAMEQ) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 531146 | NSE: MEDICAMEQ | Pharmaceuticals & Drugs | Small Cap

Medicamen Biotech Share Price

384.75 -5.50 -1.41%
as on 05-Dec'25 12:12

Medicamen Biotech Ltd (MEDICAMEQ) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 531146 | NSE: MEDICAMEQ | Pharmaceuticals & Drugs | Small Cap

DeciZen - make an informed investing decision on Medicamen Biotech

Based on:

Overall Rating
Bole Toh

1. Quality

2. Valuation

Undervalued

3. Price Trend

Medicamen Biotech stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
60.31
Market Cap:
529.3 Cr.
52-wk low:
292.5
52-wk high:
630

Is Medicamen Biotech Ltd an attractive stock to invest in?

1. Is Medicamen Biotech Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Medicamen Biotech Ltd is a below average quality company.

2. Is Medicamen Biotech Ltd undervalued or overvalued?

The key valuation ratios of Medicamen Biotech Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone.

3. Is Medicamen Biotech Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Strong which suggest that the price of Medicamen Biotech Ltd is likely to Rise in the short term. However, please check the rating on Quality and Valuation before investing

10 Year X-Ray of Medicamen Biotech:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Medicamen Biotech Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 11.4%24.1%24.9%20.2%15.3%13.1%12.8%11%10.1%7%-
Value Creation
Index
-0.20.70.80.40.1-0.1-0.1-0.2-0.3-0.5-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 67.382.5112123117110115138172151148
Sales YoY Gr.-22.6%35.2%10%-4.3%-6.1%4.8%19.4%25%-12.1%-
Adj EPS 0.14.87.78.89.21011.4119.776.5
YoY Gr.-4650%62.5%14.1%4.8%7.8%14.3%-2.9%-12.5%-27.1%-
BVPS (₹) 17.924.763.773.798.6104.5114.8146.8159.3166195.7
Adj Net
Profit
0.15910.311.312.213.91412.399
Cash Flow from Ops. 6.23.6-5.54.311.7134.8-3.5-0.3-2.6-
Debt/CF from Ops. 3.34.9-2.72.711.55.4-7.4-121.1-10.4-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 9.4%5.2%9.5%-12.1%
Adj EPS 60.4%-5.3%-14.8%-27.1%
BVPS28.1%11%13.1%4.2%
Share Price 23% -0.6% -23.2% -34.1%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
0.622.417.812.810.89.59.88.26.14.23.6
Op. Profit
Mgn %
8.214.115.114.315.518.220.917.915.811.39.6
Net Profit
Mgn %
0.26.18.18.49.6111210.17.15.95.9
Debt to
Equity
1.10.70.20.10.10.20.20.10.20.10
Working Cap
Days
230197196235287310332358342431244
Cash Conv.
Cycle
42376474716688128118173141

Recent Performance Summary

No data to display

Return on Equity has declined versus last 3 years average to 3.60%

Sales growth has been subdued in last 3 years 9.47%

Net Profit has been subdued in last 3 years -14.77%

Sales growth is not so good in last 4 quarters at -14.47%

Latest Financials - Medicamen Biotech Ltd.

Standalone Consolidated
TTM EPS (₹) 6.5 7.9
TTM Sales (₹ Cr.) 148 165
BVPS (₹.) 195.7 198.1
Reserves (₹ Cr.) 258 262
P/BV 1.99 1.97
PE 60.31 49.42
From the Market
52 Week Low / High (₹) 292.50 / 630.00
All Time Low / High (₹) 2.25 / 1219.00
Market Cap (₹ Cr.) 529
Equity (₹ Cr.) 13.6
Face Value (₹) 10
Industry PE 40.7

Management X-Ray of Medicamen Biotech:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Medicamen Biotech - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Medicamen Biotech

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales6782112123117110115138172151
Operating Expenses 627195105999091113145134
Manufacturing Costs20193022252924333636
Material Costs29374969604744537264
Employee Cost 57989915192222
Other Costs 887655991513
Operating Profit 6121717182024252717
Operating Profit Margin (%) 8.2%14.0%15.1%14.2%15.4%18.2%20.9%17.9%15.8%11.3%
Other Income 1024212226
Interest 4431122364
Depreciation 2222236677
Exceptional Items 0000000000
Profit Before Tax 161418171718171713
Tax 0145443243
Profit After Tax 05101212121515139
PAT Margin (%) 0.7%6.3%9.1%9.8%10.4%11.3%12.9%10.9%7.7%6.2%
Adjusted EPS (₹)0.54.98.610.310.010.212.211.910.57.4
Dividend Payout Ratio (%)0%0%12%10%5%10%8%8%10%13%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 18267587122134148193209218
Share Capital 10111212121212131313
Reserves 8156375110122136180196205
Minority Interest0000000000
Debt18171412101724243027
Long Term Debt4200265111
Short Term Debt1514141281119232926
Trade Payables19222231323042463841
Others Liabilities 597812111113154
Total Liabilities 6073118137176192225275292290

Fixed Assets

Gross Block3638464758116124130136138
Accumulated Depreciation17192022242632384551
Net Fixed Assets 19192524349092929186
CWIP 000154000000
Investments 0000222488
Inventories1114141517527455962
Trade Receivables16263843445061604859
Cash Equivalents 3323923420154
Others Assets 11111730374339537172
Total Assets 6073118137176192225275292290

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity 64-5412135-3-0-3
PBT 061417171718171713
Adjustment 554233791110
Changes in Working Capital 1-8-23-11-3-3-17-33-25-24
Tax Paid 00-1-4-4-4-33-3-1
Cash Flow From Investing Activity -1-2-8-15-39-18-8-8-9-2
Capex -1-2-8-16-38-18-9-6-6-2
Net Investments 0-000-200-2-4-0
Others 0001000110
Cash Flow From Financing Activity -5-133-42164283-7
Net Proceeds from Shares 1339025003130
Net Proceeds from Borrowing -1-1-2-024-1-40-0
Interest Paid -3-3-2-1-1-1-1-3-4-3
Dividend Paid 00-10-1-1-1-1-1-1
Others -10-0-3-43855-2
Net Cash Flow 0020-14-61117-6-11

Finance Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)2.7623.520.1214.9611.8610.0611.129.26.854.57
ROCE (%)11.3624.124.9120.2215.2613.1212.8210.9510.136.96
Asset Turnover Ratio1.051.241.170.960.750.60.550.550.610.52
PAT to CFO Conversion(x)N/A0.8-0.50.3311.080.33-0.2-0-0.33
Working Capital Days
Receivable Days11592105122136155175161115129
Inventory Days6755464450375195111146
Payable Days284200164138191237299302212226

Medicamen Biotech Ltd Stock News

Medicamen Biotech Ltd FAQs

The current trading price of Medicamen Biotech on 05-Dec-2025 12:12 is ₹384.8.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 04-Dec-2025 the market cap of Medicamen Biotech stood at ₹529.3.
The latest P/E ratio of Medicamen Biotech as of 04-Dec-2025 is 60.31.
The latest P/B ratio of Medicamen Biotech as of 04-Dec-2025 is 1.99.
The 52-week high of Medicamen Biotech is ₹630.0 and the 52-week low is ₹292.5.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Medicamen Biotech is ₹147.8 ( Cr.) .

About Medicamen Biotech Ltd

Medicamen Biotech Limited was incorporated in December 1993, it is a widely held, Globaly Recognized public limited company engaged in manufacturing and marketing of pharmaceutical formulations in overseas and domestic markets. Medicamen Biotech Limited is committed to produce and provide quality medicines at competitive price for domestic as well as international markets thereby being socially responsible and rendering services to the medical fraternity since inception.

Medicamen Biotech started its operation as distributor and manufacturer of medicines on loan license basis. The distribution activities were spread manifold over a wide market extending beyond the domestic market and started exporting to CIS countries.The vast distribution network with demand for low cost medicines prompted Mr. B.K. Gupta - Managing Director of the company to go for own manufacturing facilities. Thus in the later part of 1994 a land of 2,10,000 square feet in the Industrial town of Bhiwadi in the state of Rajasthan was procured.

In 1995 Medicamen Biotech Limited was enlisted in Bombay Stock Exchange and public issue was oversubscribed by more than 11 times. Within a span of 10 years Medicamen Biotech Limited is now among top 50 Indian export company.

In the year 2005 keeping the pace with the ever increasing demand and fulfilling the commitment, a second unit was installed in the Tax free zone at Haridwar in the state of Uttarakhand .The Unit II is fully operational from April 2007 with ultra modern manufacturing facilities.

Product range of the company includes:

The company is the Manufacturer and supplier of Comprehensive range of products:

  • Tablets
  • Capsules
  • Liquid Syrup
  • Dry Syrup (Beta Lactum and Non Beta Lactum)
  • Ointment
  • ORS

Achievements/ recognition:

The company is the receipents of the following certificates & awards:

  • WHO-GMP
  • ISO 9001: 2000
  • Star Export House
  • Certificate Of Merit
  • “Niryat Shree” for the four consecutive years from 2002 to 2005 from Government of India
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×